BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 12053080)

  • 1. Renal transplantation in patients with Fabry disease.
    Sessa A; Meroni M; Battini G; Maglio A; Nebuloni M; Tosoni A; Panichi V; Bertagnolio B
    Nephron; 2002 Jun; 91(2):348-51. PubMed ID: 12053080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic renal failure, dialysis, and renal transplantation in Anderson-Fabry disease.
    Sessa A; Meroni M; Battini G; Righetti M; Mignani R
    Semin Nephrol; 2004 Sep; 24(5):532-6. PubMed ID: 15490423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal ultrastructural findings in Anderson-Fabry disease.
    Sessa A; Toson A; Nebuloni M; Pallotti F; Giordano F; Battini G; Maglio A; Meroni M; Calconi G; Bertolone G; Gatti P
    J Nephrol; 2002; 15(2):109-12. PubMed ID: 12018625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal involvement in Anderson-Fabry disease.
    Sessa A; Meroni M; Battini G; Righetti M; Maglio A; Tosoni A; Nebuloni M; Vago G; Giordano F
    J Nephrol; 2003; 16(2):310-3. PubMed ID: 12774774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical spectrum of Anderson Fabry disease in a Romanian family.
    Tudor A; Muşat A; Doscan A; Bari M; Zapucioiu C; Urdea E; Cochior D; Peţa D
    Rom J Intern Med; 2006; 44(2):201-10. PubMed ID: 17236300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel frameshift mutation in a heterozygous woman with Fabry disease and end-stage renal failure.
    Van Loo A; Vanholder R; Madsen K; Praet M; Kint J; De Paepe A; Messiaen L; Lameire N; Hasholt L; Sørensen SA; Ringoir S
    Am J Nephrol; 1996; 16(4):352-7. PubMed ID: 8739292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term Outcomes of Kidney Transplantation in Fabry Disease.
    Ersözlü S; Desnick RJ; Huynh-Do U; Canaan-Kühl S; Barbey F; Genitsch V; Mueller TF; Cheetham M; Flammer AJ; Schaub S; Nowak A
    Transplantation; 2018 Nov; 102(11):1924-1933. PubMed ID: 29688992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined heart and kidney transplantation in a patient with Fabry disease in the enzyme replacement therapy era.
    Karras A; De Lentdecker P; Delahousse M; Debauchez M; Tricot L; Pastural M; Bruneval P; Zemoura L; Duong Van Huyen JP; Lidove O
    Am J Transplant; 2008 Jun; 8(6):1345-8. PubMed ID: 18522550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal pathological changes in Fabry disease.
    Sessa A; Meroni M; Battini G; Maglio A; Brambilla PL; Bertella M; Nebuloni M; Pallotti F; Giordano F; Bertagnolio B; Tosoni A
    J Inherit Metab Dis; 2001; 24 Suppl 2():66-70; discussion 65. PubMed ID: 11758681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal variant of Anderson-Fabry disease and bilateral renal cell carcinoma.
    Blanco J; Herrero J; Arias LF; Garcia-Miralles N; Gamez C; Barrientos A
    Pathol Res Pract; 2005; 200(11-12):857-60. PubMed ID: 15792133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early renal failure in childhood in a male with Fabry disease.
    Hogh JN; Ebrahim H; Moochhala S; Ramaswami U
    BMJ Case Rep; 2022 May; 15(5):. PubMed ID: 35537774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fabry disease: molecular genetics of the inherited nephropathy.
    Desnick RJ; Astrin KH; Bishop DF
    Adv Nephrol Necker Hosp; 1989; 18():113-27. PubMed ID: 2564247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal transplantation between siblings with unrecognized Fabry disease.
    Taneda S; Honda K; Nakajima I; Huchinoue S; Oda H
    Transplant Proc; 2013; 45(1):115-8. PubMed ID: 23375284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unexpected Fabry disease in a renal allograft kidney: an underrecognized cause of poor allograft function.
    Kochar O; Wick MR; Kerr SE; Oglesbee D; Cathro HP
    Ultrastruct Pathol; 2011 Apr; 35(2):92-6. PubMed ID: 21299350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anderson-Fabry disease].
    Kes P; Basić-Jukić N; Brunetta B; Jurić I
    Acta Med Croatica; 2006; 60(1):55-8. PubMed ID: 16802573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and pharmacokinetics of agalsidase alfa in patients with Fabry disease and end-stage renal disease.
    Pastores GM; Boyd E; Crandall K; Whelan A; Piersall L; Barnett N
    Nephrol Dial Transplant; 2007 Jul; 22(7):1920-5. PubMed ID: 17395657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anderson-Fabry disease and renal transplantation].
    Basić-Jukić N; Kes P; Hudolin T; Mesar I; Corić M; Kastelan Z
    Acta Med Croatica; 2011; 65(4):377-80. PubMed ID: 22359912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kidney transplantation and enzyme replacement therapy in patients with Fabry disease.
    Cybulla M; Kurschat C; West M; Nicholls K; Torras J; Sunder-Plassmann G; Feriozzi S
    J Nephrol; 2013; 26(4):645-51. PubMed ID: 23023720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrastructural study of renal involvement in two females with Anderson-Fabry disease.
    Tosoni A; Nebuloni M; Zerbi P; Vago L; Comotti C; Sessa A
    Ultrastruct Pathol; 2005; 29(3-4):203-7. PubMed ID: 16036875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal involvement in paediatric Fabry disease.
    Sestito S; Falvo F; Sallemi A; Petrisano M; Scuderi MG; Tarsitano F; D'Angelo G; Betta P; Roppa K; Parisi F; Pensabene L; Fede C; Chimenz R; Concolino D
    J Biol Regul Homeost Agents; 2019; 33(5 Suppl. 1):59-63. Special Issue: Focus on Pediatric Nephrology. PubMed ID: 31630715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.